Factors correlated with improvement of endothelial dysfunction during rituximab therapy in patients with rheumatoid arthritis
Maurizio Benucci,1 Gianantonio Saviola,2 Mariangela Manfredi,3 Piercarlo Sarzi-Puttini,4 Fabiola Atzeni41Rheumatology Unit, Department of Internal Medicine, Hospital di S Giovanni di Dio, Azienda Sanitaria di Firenze, Florence, Italy; 2Rheumatology and Rehabilitation Unit, Salvatore Maugeri Foundati...
Guardado en:
Autores principales: | Benucci M, Saviola G, Manfredi M, Sarzi-Puttini P, Atzeni F |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ad8fe6c0e9104037889e1751485fb32b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Factors correlated with the improvement of endothelial dysfunction during Abatacept therapy in patients with rheumatoid arthritis
por: Benucci M, et al.
Publicado: (2018) -
Correlations between immunogenicity, drug levels, and disease activity in an Italian cohort of rheumatoid arthritis patients treated with tocilizumab
por: Benucci M, et al.
Publicado: (2016) -
Rituximab therapy in Greek patients with rheumatoid arthritis
por: Haralampos M Moutsopoulos, et al.
Publicado: (2008) -
B cell reductive therapy with rituximab in the treatment of rheumatoid arthritis
por: Joseph M Tuscano, et al.
Publicado: (2009) -
Update on the use of rituximab for intractable rheumatoid arthritis
por: R John Looney
Publicado: (2009)